These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33297469)
1. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. García P; Lamarca A; Díaz J; Carrera E; Roa JC; On Behalf Of The European-Latin American Escalon Consortium Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297469 [TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer. Lin HZ; Zhang T; Chen MY; Shen JL J Dig Dis; 2021 Feb; 22(2):62-71. PubMed ID: 33369216 [TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility. Srivastava A; Tulsyan S; Pandey SN; Choudhuri G; Mittal B Liver Int; 2009 Jul; 29(6):831-7. PubMed ID: 19018975 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA aberrations: An emerging field for gallbladder cancer management. Chandra V; Kim JJ; Mittal B; Rai R World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538 [TBL] [Abstract][Full Text] [Related]
6. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians. Sakai K; Loza E; Roig GV; Nozaki R; Asai T; Ikoma T; Tsuchiya Y; Kiyohara C; Yamamoto M; Nakamura K Asian Pac J Cancer Prev; 2016; 17(2):781-4. PubMed ID: 26925680 [TBL] [Abstract][Full Text] [Related]
7. Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Srivastava K; Srivastava A; Kumar A; Mittal B Liver Int; 2010 Aug; 30(7):1067-72. PubMed ID: 20492496 [TBL] [Abstract][Full Text] [Related]
8. Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility. Sharma KL; Agarwal A; Misra S; Kumar A; Kumar V; Mittal B Tumour Biol; 2014 Jun; 35(6):5431-9. PubMed ID: 24535777 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review. Saqib R; Pathak S; Smart N; Nunes Q; Rees J; Finch Jones M; Poston G ANZ J Surg; 2018 Jun; 88(6):554-559. PubMed ID: 29205753 [TBL] [Abstract][Full Text] [Related]
17. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population. Pandey SN; Choudhuri G; Mittal B Eur J Cancer Prev; 2008 Apr; 17(2):77-81. PubMed ID: 18287863 [TBL] [Abstract][Full Text] [Related]
18. Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer. Maplanka C J Gastrointest Cancer; 2014 Sep; 45(3):245-55. PubMed ID: 24652122 [TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of gallbladder cancer: An update. Mishra SK; Kumari N; Krishnani N Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366 [TBL] [Abstract][Full Text] [Related]
20. Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. Sinha SR; Prakash P; Singh RK; Sinha DK World J Gastrointest Surg; 2022 Nov; 14(11):1272-1284. PubMed ID: 36504513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]